Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-053497

SVP, COO & CFO sold 25,000 shares at $15.83 ($395,750)

  • SVP, COO & CFO acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2019-10-15 Option exercise +25,000 $7.21 $180,250 252,872 D
Labrucherie Gil M SVP, COO & CFO 2019-10-15 Sale −25,000 $15.83 $395,750 227,872 D
Derivatives
Labrucherie Gil M SVP, COO & CFO 2019-10-15 Option exercise · Stock Option −25,000 25,000 D
Open-market sales · 25,000 sh · avg $15.83 · $395,750
Loading xslF345X03/doc4.xml…